Mirador Therapeutics
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$1.15B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mirador Therapeutics is a biotechnology company that develops precision medicines for immune-mediated inflammatory and fibrotic diseases using its proprietary Mirador360™ discovery and development engine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirador Therapeutics Comparables
Compare Mirador Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insitro | 82% | |
| Seismic | 82% | |
| Odyssey Therapeutics | 81% | |
Mirador Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Series B | Sep 30, 2025 | ||||
| Series A | Mar 21, 2024 |
Mirador Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Farallon Capital Management | Series B, Series A |
| TCG Crossover | Series B, Series A |
| Boxer Capital | Series B, Series A |
| Fairmount Funds Management | Series B, Series A |
| ARCH Venture Partners | Series B, Series A |
| Fidelity Management & Research Company | Series B, Series A |
| Blue Owl Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
$250M round with participation from Venrock and Adage Capital.
- Jan 1, 2026
Certified as a Great Place To Work®.
Mirador Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mirador Therapeutics's valuation, stock price, and market status.